Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient mice
Open Access
- 31 July 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Lipids in Health and Disease
- Vol. 11 (1), 96
- https://doi.org/10.1186/1476-511x-11-96
Abstract
Stem/progenitor cell-based therapy has successfully been used as a novel therapeutic strategy for vascular diseases triggered by endothelial dysfunction. The aim of this study was to investigate the effects of mononuclear cell (MNC) therapy in situ on carotid cuff-induced occlusive thrombus in the apolipoprotein E knockout (apoE-/-) mouse. Spleen-derived MNCs were isolated from green fluorescent protein (GFP)-transgenic mice for cell treatment. A cuff-induced thrombus model was produced by placing a nonconstrictive silastic collar around the left common carotid artery in 20-week-old female apoE-/- mice. After 10 days, the cuff was removed, and the animals received in situ MNCs (Cuff-MNC) or vehicle (Cuff-Vehicle) and were compared with sham-operated animals (Sham). The histological analysis showed that the MNC treatment reverted occlusive thrombus formation compared to the vehicle and the vessel lumen area to that observed in the Sham group (MNC, 50 ± 4; Vehicle, 20 ± 4; Sham, 55 ± 2 x103 μm2; p < 0.01). The animals that underwent the carotid cuff placement developed compensatory vessel enlargement, which was reduced by the MNC therapy. In addition, the treatment was able to reduce superoxide anion production, which likely contributed to the reduced apoptosis that was observed. Lastly, the immunofluorescence analysis revealed the presence of endothelial progenitor cells (EPCs) in the carotid endothelia of the apoE-/- mice. In situ short-term MNC therapy was able to revert cuff-induced occlusive thrombi in the carotid arteries of apoE-/- mice, possibly through the homing of EPCs, reduction of oxidative stress and decreased apoptosis.Keywords
This publication has 43 references indexed in Scilit:
- Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouseJournal of Biomedical Science, 2012
- Strategies to Reverse Endothelial Progenitor Cell Dysfunction in DiabetesExperimental Diabetes Research, 2012
- Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: insights into the influence of diet, gender and agingLipids in Health and Disease, 2011
- Mononuclear cell therapy attenuates atherosclerosis in apoE KO miceLipids in Health and Disease, 2011
- Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient miceJournal of Lipid Research, 2010
- Cardiac and vascular changes in elderly atherosclerotic mice: the influence of genderLipids in Health and Disease, 2010
- Endothelial dysfunction of resistance vessels in female apolipoprotein E-deficient miceLipids in Health and Disease, 2010
- Microvascular Responses to Cardiovascular Risk FactorsMicrocirculation, 2010
- Diabetes Impairs the Vascular Recruitment of Normal Stem Cells by Oxidant Damage, Reversed by Increases in pAMPK, Heme Oxygenase-1, and AdiponectinThe International Journal of Cell Cloning, 2009
- Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivoThe Journal of Experimental Medicine, 2006